Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VSBC Stock Summary
In the News
VSBC Financial details
Company Rating
Neutral
Market Cap
3.3B
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
21 Dec 2022
P/E
2607.39
Forward P/E
-
PEG
-
P/S
608.29
P/B
2089.17
P/C
-
P/FCF
289018.5
Quick Ratio
1.97
Current Ratio
1.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
35%
ROE
151%
ROC
0.72%
Gross Margin
37%
Oper. Margin
26%
Profit Margin
23%
Payout
-
Shs Outstand
206.52M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
10.0-16.5
52W High
-
52W Low
-
RSI
-
Rel Volume
2.15
Avg Volume
93
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.188
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
VSBC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
Metric | History | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0.03 | 0 | |
Net income per share | 0 | 0 | 0 | 0.01 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0.01 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0.01 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0.01 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 22.89M | 22.89M | 1.09B | 2.88B | 0 | |
Enterprise value | 22.91M | 22.89M | 1.09B | 2.88B | 0 | |
P/E ratio | -1.02K | 942.5 | -2.57K | 2.28K | 0 | |
Price to sales ratio | 1.33K | 1.51K | 4.4K | 513.75 | 0 | |
POCF ratio | -668.48 | -218.04K | -25.95K | 34K | 0 | |
PFCF ratio | -668.48 | -218.04K | -25.95K | 244.1K | 0 | |
P/B Ratio | -3.31K | -1.25K | 11.34K | 1.83K | 0 | |
PTB ratio | -3.31K | -1.25K | 11.34K | 1.83K | 0 | |
EV to sales | 1.33K | 1.51K | 4.4K | 513.81 | 0 | |
Enterprise value over EBITDA | -1.04K | -628.77 | -2.57K | 1.93K | 0 | |
EV to operating cash flow | -669.02 | -218.04K | -25.94K | 34.01K | 0 | |
EV to free cash flow | -669.02 | -218.04K | -25.94K | 244.13K | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | -2.65 | 0 | 0 | 0.29 | 0 | |
Debt to assets | 1.61 | 0 | 0 | 0.13 | 0 | |
Net debt to EBITDA | -0.83 | 0 | 0.11 | 0.24 | 0 | |
Current ratio | 0.55 | 0 | 2.04 | 1.97 | 0 | |
Interest coverage | 0 | 0 | -634.9 | -627.59 | 0 | |
Income quality | 1.53 | -0.02 | 0.1 | 0.07 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.1 | 1.37 | 2.16 | 0.1 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.86 | 0 | |
Capex to revenue | 0 | 0 | 0 | -0.01 | 0 | |
Capex to depreciation | 0 | 0 | 0 | -8.73 | 0 | |
Stock based compensation to revenue | 0 | 0 | 1.75 | 0.03 | 0 | |
Graham number | 0 | 0 | 0.01 | 0.03 | 0 | |
ROIC | -1.96 | 3.75 | -4.41 | 0.5 | 0 | |
Return on tangible assets | -1.96 | 0 | -2.25 | 0.35 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | -8.34K | 0 | 96.36K | 1.51M | 0 | |
Tangible asset value | -6.92K | 0 | 96.36K | 1.58M | 0 | |
Net current asset value | -8.34K | 0 | 96.36K | 1.04M | 0 | |
Invested capital | -2.65 | 0 | 0 | 0.29 | 0 | |
Average receivables | 0 | 0 | 0 | 1.48M | 1.48M | |
Average payables | 705 | 0 | 0 | 625.75K | 625.75K | |
Average inventory | 7.15K | 4.25K | 72K | 72K | 0 | |
Days sales outstanding | 0 | 0 | 0 | 191.96 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 128.85 | 0 | |
Days of inventory on hand | 895.31 | 0 | 386.47 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 1.9 | 0 | |
Payables turnover | 0 | 0 | 0 | 2.83 | 0 | |
Inventory turnover | 0.41 | 0 | 0.94 | 0 | 0 | |
ROE | 3.24 | -1.33 | -4.41 | 0.8 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-10-31 for Q3
Metric | History | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.01 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0.01 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0.01 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 3.07B | 0 | 0 | 0 | 0 | |
Enterprise value | 3.07B | 0 | 0 | 0 | 0 | |
P/E ratio | -5.56K | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 1.25M | 0 | 0 | 0 | 0 | |
PFCF ratio | 1.25M | 0 | 0 | 0 | 0 | |
P/B Ratio | 1.82K | 0 | 0 | 0 | 0 | |
PTB ratio | 1.82K | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -17.12K | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 1.25M | 0 | 0 | 0 | 0 | |
EV to free cash flow | 1.25M | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.2 | 0 | 0 | 0 | 0 | |
Debt to assets | 0.13 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -1.71 | 0 | 0 | 0 | 0 | |
Current ratio | 4.33 | 0 | 0 | 0 | 0 | |
Interest coverage | -287.19 | 0 | 0 | 0 | 0 | |
Income quality | -0.02 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.01 | 0 | 0 | 0 | 0 | |
ROIC | -0.06 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.06 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 1.58M | 0 | 0 | 0 | 0 | |
Tangible asset value | 1.68M | 0 | 0 | 0 | 0 | |
Net current asset value | 1.29M | 0 | 0 | 0 | 0 | |
Invested capital | 0.2 | 0 | 0 | 0 | 0 | |
Average receivables | 2.07M | 1.01M | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | -1.01M | -1.01M | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | -48.28K | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.08 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
VSBC Frequently Asked Questions
What is VitaSpring Biomedical Co. Ltd. stock symbol ?
VitaSpring Biomedical Co. Ltd. is a US stock , located in Irvine of Ca and trading under the symbol VSBC
What is VitaSpring Biomedical Co. Ltd. stock quote today ?
VitaSpring Biomedical Co. Ltd. stock price is $- today.
Is VitaSpring Biomedical Co. Ltd. stock public?
Yes, VitaSpring Biomedical Co. Ltd. is a publicly traded company.